Journal of Interferon & Cytokine Research · 2005 · 293 citations · 33 references
Veterinary MedicineImmunologyInfectious DiseasesHost-pathogen InteractionsImmunology Of Infectious DiseasesInnate ImmunityImmune Responses To InfectionImmunopathology Of Infectious DiseasesInnate Immune ActivationInnate Immune ResponseInnate Immune Signaling PathwaysInterferon ResponsesHost Response MarkersInterferon Signaling ResponsesInterleukin-12 SignalingMurine ModelsMycobacterium Tuberculosis InfectionMycobacterium Tuberculosis PathogenesisType I Interferon PathwaysType I Interferon Responses
The role of type I interferons (IFNs) in the host response to bacterial infections is controversial. Here, we examined the role of IFN-alpha/beta in the murine response to infection with Mycobacterium tuberculosis, using wildtype mice, mice with impaired signaling through the type I IFN receptor (IFNAR), and mice treated to reduce levels of type I IFNs. In this study, we used virulent clinical isolates of M. tuberculosis, including HN878, W4, and CDC1551. Our results indicate that higher levels of type I IFNs are induced by the HN878 and W4 strains. Induction of type I IFNs was associated with lower levels of tumor necrosis factor-alpha (TNF-alpha) and interleukin- 12 (IL-12) and reduced T cell activation, and associated with decreased survival of the mice infected with HN878 or W4 relative to infection with CDC1551. Infection of mice with HN878 and W4 was also associated with relatively higher levels of mRNA for a number of negative regulators of the Jak-Stat signaling pathway, such as suppressors of cytokine signaling (SOCS) 1, 4, and 5, CD45, protein inhibitor of activated Stat1 (PIAS1), protein tyrosine phosphatase nonreceptor type 1 (Ptpn1), and protein tyrosine phosphatase nonreceptor type substrate 1 (Ptpns1). Taken together, these results suggest that increased type I IFNs may be deleterious for survival of M. tuberculosis-infected mice in association with reduced Th1 immunity.
33
Functional Role of Type I and Type II Interferons in Antiviral Defense
Ulrike Müller, Ulrich Steinhoff, Luiz F. L. Reis et al. · Science · 1994 · 2.5K citations · Full text
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
Michael B. Reed, Pilar Domenech, Claudia Manca et al. · Nature · 2004 · 752 citations
Claudia Manca, Liana Tsenova, Amy Bergtold et al. · Proceedings of the National Academy of Sciences · 2001 · 601 citations · Full text